Reproductive Toxicity Factors Weighted Equally To Guard Against Bias - FDA
Executive Summary
Seven reproductive toxicity criteria will be considered with equal weight in order to promote consistency and avoid investigator biases in assessing preclinical reproductive toxicity data, members of FDA's reproductive toxicity working group decided.
You may also be interested in...
Medco “Whistleblowers” Include Ex-Employees, False Claims Professional
The Medco "whistleblower" cases indicate the extent to which participants in the pharmaceutical sector are vulnerable to False Claims Act cases
PBM Fees Under Medicare Would Be Reported To DoJ, HHS In Senate Bill
PBMs administering Medicare drug plans would be required to report all payments received from drug manufacturers to the Department of Justice and the HHS Inspector General under the Senate's Medicare legislation
Medco “Whistleblowers” Include Ex-Employees, False Claims Professional
The Medco "whistleblower" cases indicate the extent to which participants in the pharmaceutical sector are vulnerable to False Claims Act cases